Befejeződött1. fázis
A study to test Aumolertinib in European participants with genetically linked advanced Lung Cancer
Key facts
- Where
- Sofiya, BulgáriaSee the site
- Phase
- 1. fázis
Where in Bulgária
- Multispecialty hospital for active treatment Sveta Sofia EOODSofiya, BulgáriaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Jiangsu Hansoh Pharmaceutical Group Co. Ltd.
- Trial code
- EU 2024-519618-29-00
- Record updated
- 2025. augusztus 14.